Scientists Warn Of Disturbing Rise In Vitamin K Deficiency Among Newborns

According to health expert, babies are born with little vitamin K, leaving them vulnerable to bleeding that can cause permanent brain damage or death. A single shot helps protect against that danger. The American Academy of Pediatrics has recommended one dose injected into a muscle for newborns since 1961, and a growing number of American parents are choosing to skip it. That trend has coincided with a sharp rise in diagnoses of vitamin K deficiency (VKD) and vitamin-K-deficient bleeding (VKDB). A nationwide study found that their rates increased by 216 percent and 347 percent, respectively, between 2017 and 2025, while the percentage of newborns receiving injectable vitamin K fell from 97.7 percent to 95.0 percent. The findings were published on November 5, 2026, in JAMA Pediatrics.
Bleeding risk can last for months Vitamin K activates specialized proteins needed for normal blood clotting. Newborns receive too little through the placenta, absorb it poorly through their digestive systems, and get little from breast milk. The injection addresses a deficiency at a time when its consequences can be severe. Classical VKD occurs between 2 days and 1 week after birth and causes bruising and bleeding from the umbilicus, or belly button. Late VKD, which occurs between 1 week and 6 months of age, carries a 30% to 60 percent risk of intracranial hemorrhage, or bleeding inside the skull.
That bleeding can lead to seizures, permanent brain damage, or death. Bleeding diagnoses rise as injections decline Refusal of the shot has increased over the past decade. Previous studies found that the proportion of newborns who did not receive intramuscular vitamin K rose from 2.9 percent in 2017 to 5.2 percent in 2024. To investigate the consequences of that trend, pediatrician at Children’s Hospital of Richmond at Virginia Commonwealth University (VCU) and an associate professor in the Department of Pediatrics at Virginia Commonwealth University School of Medicine, Elizabeth Wolf led the new nationwide study. The researchers analysed de-identified electronic health records from a large national database covering health systems across the United States. Their analysis included more than 11 million infants aged 0 to 6 months who were born at 35 weeks’ gestation or later and received care between 2017 and 2025.
Only 40 percent of infants diagnosed with VKD and about 19 percent of those diagnosed with VKDB had received vitamin K shots. About seven percent of infants with VKD and two percent of those with VKDB also had a diagnosis of intracranial or intracerebral hemorrhage, meaning bleeding inside the skull or within the brain tissue itself. “We knew from prior studies that vitamin K refusal had been increasing in the U.S., and we wanted to learn if there were any real-life consequences of this trend. We found that the answer is undeniably yes, with the rates of VKD and VKDB multiplying over the course of our study,” Wolf said. The researchers caution that the simultaneous decline in injections and increase in diagnoses does not prove causation.
Wolf considers other explanations unlikely, however, because behaviors and diseases that increase the risk of VKD remained constant or decreased during the study period. The study’s co-authors included Steven Woolf, director emeritus of the VCU Centre on Society and Health and a professor in VCU School of Medicine’s Department of Family Medicine, Evan French, MS, of VCU’s C. Kenneth and Dianne Wright Center for Clinical and Translational Research, and Darya Shokouhi Niaki, Pharm.D., of the VCU School of Public Health’s Department of Biostatistics.



